MIRM - Mirum Pharmaceuticals Inc
IEX Last Trade
43.11
1.130 2.621%
Share volume: 331,362
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$41.98
1.13
2.69%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-09 | 2023-03-08 | 2023-05-04 | 2023-08-07 | 2023-11-02 | 2024-03-15 | 2024-05-08 | |
| Total revenue | 17.484 M | 18.780 M | 27.906 M | 31.598 M | 37.497 M | 47.725 M | 69.554 M | 69.222 M | |
| Cost of revenue | 2.524 M | 2.932 M | 4.494 M | 4.979 M | 6.812 M | 10.228 M | 25.020 M | 17.830 M | |
| Gross profit | 14.960 M | 15.848 M | 23.412 M | 26.619 M | 30.685 M | 37.497 M | 44.534 M | 51.392 M | |
| 5.94% | 47.73% | 13.70% | 15.27% | 22.20% | 18.77% | 15.40% | |||
| Operating expenses | 46.401 M | 48.730 M | 57.573 M | 53.767 M | 54.958 M | 62.645 M | 77.119 M | 77.860 M | |
| Selling general and admin | 20.969 M | 22.513 M | 26.468 M | 30.219 M | 32.949 M | 36.528 M | 46.184 M | 45.638 M | |
| Research and development | 25.432 M | 26.217 M | 31.105 M | 23.548 M | 22.009 M | 26.117 M | 30.935 M | 32.222 M | |
| Total expenses | 48.925 M | 51.662 M | 62.067 M | 58.746 M | 61.770 M | 72.873 M | 102.139 M | 95.690 M | |
| 5.59% | 20.14% | -5.35% | 5.15% | 17.97% | 40.16% | -6.31% | |||
| Operating income | -31.441 M | -32.882 M | -34.161 M | -27.148 M | -24.273 M | -25.148 M | -32.585 M | -26.468 M | |
| Ebit | -31.441 M | -32.882 M | -34.161 M | -27.148 M | -24.273 M | -25.148 M | -32.585 M | -26.468 M | |
| Pretax income | -33.492 M | -35.693 M | -36.291 M | -29.929 M | -73.722 M | -23.339 M | -35.434 M | -24.655 M | |
| 6.57% | 1.68% | -17.53% | 146.32% | -68.34% | 51.82% | -30.42% | |||
| Income tax | -6.570 M | 13.000 K | 140.000 K | 201.000 K | 316.000 K | 249.000 K | 225.000 K | 624.000 K | |
| Net income basic | -26.922 M | -35.706 M | -36.431 M | -30.130 M | -74.038 M | -23.588 M | -35.659 M | -25.279 M | |
| -32.63% | -2.03% | 17.30% | -145.73% | 68.14% | -51.17% | 29.11% | |||
| Net income | -26.922 M | -35.706 M | -36.431 M | -30.130 M | -74.038 M | -23.588 M | -35.659 M | -25.279 M | |
| -32.63% | -2.03% | 17.30% | -145.73% | 68.14% | -51.17% | 29.11% |